Related references
Note: Only part of the references are listed.Rescue of Ca2+ overload-induced left ventriclur dysfunction by targeted ablation of phospholamban
Tsuyoshi Tsuji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy
Lennart Suckau et al.
CIRCULATION (2009)
Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury
Persoulla Nicolaou et al.
CIRCULATION RESEARCH (2009)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
Brian E. Jaski et al.
JOURNAL OF CARDIAC FAILURE (2009)
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology
Persoulla Nicolaou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation
Larissa Lipskaia et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Lin Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo
J. Michael O'Donnell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Calcium cycling and signaling in cardiac myocytes
Donald M. Bers
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion
Fabrice Prunier et al.
CIRCULATION (2008)
Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
Gene therapy in heart failure
Leif Erik Vinge et al.
CIRCULATION RESEARCH (2008)
Endothelial S100A1 modulates vascular function via nitric oxide
Sven T. Pleger et al.
CIRCULATION RESEARCH (2008)
Optimizing gene delivery vectors for the treatment of heart disease
Steven J. Gray et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals
M. J. Byrne et al.
GENE THERAPY (2008)
Gene therapy: targeting the myocardium
A. R. Lyon et al.
HEART (2008)
Intracellular devastation in heart failure
Federica del Monte et al.
HEART FAILURE REVIEWS (2008)
Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients
Wilfried Mullens et al.
HEART RHYTHM (2008)
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
Roger J. Hajjar et al.
JOURNAL OF CARDIAC FAILURE (2008)
Modulation of sarcoplasmic reticulum function by PST2744 [Istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride] in a pressure-overload heart failure model
Marcella Rocchetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure
Christian Butter et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy
Marc Vanderheyden et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure
Yoshiaki Kawase et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Recombinant adeno-associated virus transduction and integration
Brian R. Schultz et al.
MOLECULAR THERAPY (2008)
Engineering and selection of shuffled AAV genomes: A new strategy for producing targeted biological nanoparticles
Wuping Li et al.
MOLECULAR THERAPY (2008)
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny
James T. Koerber et al.
MOLECULAR THERAPY (2008)
The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases
Yoshiaki Kawase et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
The sarcoplasmic reticulum and arrhythmogenic calcium release
Luigi A. Venetucci et al.
CARDIOVASCULAR RESEARCH (2008)
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors
P. W. Raake et al.
GENE THERAPY (2008)
S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance
Patrick Most et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Percutaneous cardiac recirculation-mediated gene TranSimer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals
David M. Kaye et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo
J. Palomeque et al.
GENE THERAPY (2007)
Mutation of δ-sarcoglycan is associated with Ca2+-dependent vascular Syrian hamster
Larissa Lipskaia et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Treatment of heart failure by calcium cycling gene therapy
Larissa Lipskaia et al.
FUTURE CARDIOLOGY (2007)
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue
Sven T. Pleger et al.
CIRCULATION (2007)
Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins
Susumu Sakata et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Calcium waves driven by sensitization wave-fronts
Markus Keller et al.
CARDIOVASCULAR RESEARCH (2007)
Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a Type 2 diabetic rat model
Susumu Sakata et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Targeting the heart with gene therapy-optimized gene delivery methods
Oliver J. Mueller et al.
CARDIOVASCULAR RESEARCH (2007)
Lipopolysaccharide activates calcineurin in ventricular myocytes
Jun Suzuki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Istaroxime, a stimulator of sarcoplasmic, reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure
Rosella Micheletti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
SERCA pump isoforms: Their role in calcium transport and disease
Muthu Periasamy et al.
MUSCLE & NERVE (2007)
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A. Pacak et al.
CIRCULATION RESEARCH (2006)
A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span
Peter Vangheluwe et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer
Susumu Sakata et al.
MOLECULAR THERAPY (2006)
Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth
Qinghang Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Diastolic dysfunction in human cardiac allografts is related with reduced SERCA2a gene expression
R Stüdeli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy
K Haghighi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat
L Lipskaia et al.
CIRCULATION RESEARCH (2005)
Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure
T Dieterle et al.
CARDIOVASCULAR RESEARCH (2005)
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade
M Hayase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Effects of adeno-associated virus DNA hairpin structure on recombination
VW Choi et al.
JOURNAL OF VIROLOGY (2005)
How many Ca2+ATPase isoforms are expressed in a cell type?: A growing family of membrane proteins illustrated by studies in platelets
R Bobe et al.
PLATELETS (2005)
Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function
MT Ziolo et al.
CIRCULATION RESEARCH (2005)
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1
A Pathak et al.
CIRCULATION RESEARCH (2005)
Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias
Y Chen et al.
CIRCULATION (2004)
Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling
F del Monte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy
CMN Terracciano et al.
CIRCULATION (2004)
Phospholamban: A crucial regulator of cardiac contractility
DH MacLennan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
JP Schmitt et al.
SCIENCE (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth
BJ Wilkins et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
BD Lowes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Targeting phospholamban by gene transfer in human heart failure
F del Monte et al.
CIRCULATION (2002)
Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart
M Ver Heyen et al.
CIRCULATION RESEARCH (2001)
Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca2+-ATPase in a rat model of heart failure
F del Monte et al.
CIRCULATION (2001)
In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors
MJ Wright et al.
BASIC RESEARCH IN CARDIOLOGY (2001)
SERCA2a overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes
K Davia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Share Paper
